New ways to treat nerve pain from diabetes
Official title: Targeting methylglyoxal-induced diabetic neuropathic pain through the integrated stress response
Funded at University of Texas Dallas · NIH-11145851 · Data updated 2026-11-12
This project explores how a chemical byproduct called methylglyoxal contributes to nerve pain in people with diabetes, hoping to find better treatments.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Dallas NIH-funded |
| Lab location | 1 site (Richardson, United States) |
| Project start | September 7, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $634,061 |
| NIH project number | 5R01DK134893-03 |
| Project ID | NIH-11145851 on NIH RePORTER |
Who could benefit from this research
✓Could help
This research is foundational and does not directly recruit patients, but future clinical trials would likely seek individuals with diabetic neuropathic pain.
✕Less likely to help
Patients whose pain is not related to diabetes or the specific biological pathways being studied may not directly benefit from this particular line of research.
What this research studies
Many people with diabetes experience chronic nerve pain that is difficult to manage with current medications. This research focuses on a chemical called methylglyoxal (MGO), which is often found at higher levels in individuals with diabetes and is linked to pain. We believe MGO triggers a specific 'stress response' within nerve cells, making them overly sensitive and causing pain signals. Our goal is to understand how this stress response makes nerve cells more excitable and to identify new targets to block this process, potentially leading to more effective pain relief for diabetic patients.
Why it matters
Potential benefit: If successful, this research could lead to new medications that specifically target the causes of diabetic nerve pain, offering better relief than current treatments.
How similar studies have gone: Preliminary work in laboratory models has shown promising results, suggesting that targeting this stress response pathway could be a novel approach to treating diabetic nerve pain.
Where this research is happening
-
University of Texas Dallas
Richardson, United States Active
Researchers
- Principal investigator: Yousuf, Muhammad Saad — University of Texas Dallas
- Study coordinator: Yousuf, Muhammad Saad
Related research
Other NIH-funded projects on the same topics.
-
Peripheral nerve stimulation for chronic neuropathic pain in a new mechanistic trial
A study at Stanford tests whether a painless-sounding electrical nerve treatment helps people with long-standing neuropathic pain when added to standard care.
-
Keratinocytes and nerve pain in chemotherapy patients
A study tests a new approach to reduce painful nerve damage from chemotherapy by targeting skin cells called keratinocytes.
-
High-frequency brain stimulation for trigeminal neuropathic pain
A large, multi-site trial tests a non-invasive brain stimulation method to relieve chronic facial nerve pain for adults who have not found relief from other treatments.
-
Programmable lithium-delivery devices for pain relief without motor loss
A new bioelectronic system uses a safe lithium source and AI-powered control to deliver targeted pain relief for neuropathic pain, aiming to spare motor function.
-
Glial-nerve conversations in neuropathic pain and diabetes
This grant looks at how supportive brain and nerve cells communicate with pain-sensing neurons to understand and reduce chronic nerve pain in people.
-
Parmodulins with Low Abuse Potential for Neuropathic Pain
A new class of pain medicines called parmodulins is being studied to help people with nerve-pain pain without high abuse risk.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.